BIND Therapeutics To Report First Quarter 2014 Financial Results On May 8, 2014

Published: May 01, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will report first quarter 2014 financial results on Thursday, May 8, 2014. BIND’s management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time on Thursday, May 8, 2014 to discuss the quarterly results and recent business developments.

Help employers find you! Check out all the jobs and post your resume.

Back to news